Gold nanoparticles induce G2/M cell cycle arrest and enhance the expression of E-cadherin in breast cancer cells

References

• Siegel, R. L.; Miller, K. D.; Jemal, A. Cancer Statistics, 2018. CA: Cancer J. Clin. 2018, 68, 7–30. DOI: 10.3322/caac.21442.
   PubMed Web of Science ®Google Scholar
• Gao, X.; Reid, M. A.; Kong, M.; Locasale, J. W. Metabolic Interactions with Cancer Epigenetics. Mol. Aspects Med. 2017, 54, 50–57. DOI: 10.1016/j.mam.2016.09.001.
   PubMed Web of Science ®Google Scholar
• Duruisseaux, M.; Esteller, M. Lung Cancer Epigenetics: From Knowledge to Applications. Semin. Cancer Biol. 2018, 51, 116–128. DOI: 10.1016/j.semcancer.2017.09.005.
   PubMed Web of Science ®Google Scholar
• Lopez-Gomez, M.; Malmierca, E.; de Gorgolas, M.; Casado, E. Cancer in Developing Countries: The Next Most Preventable Pandemic. The Global Problem of Cancer. Crit. Rev. Oncol. Hematol. 2013, 88, 117–122. DOI: 10.1016/j.critrevonc.2013.03.011.
   PubMed Web of Science ®Google Scholar
• Rottenberg, Y.; Naeim, A.; Uziely, B.; Peretz, T.; Jacobs, J. M. Breast Cancer among Older Women: The Influence of Age and Cancer Stage on Survival. Archiv. Gerontol. Geriatrics 2018, 76, 60–64. DOI: 10.1016/j.archger.2018.02.004.
   PubMed Web of Science ®Google Scholar
• van Maaren, M. C.; Lagendijk, M.; Tilanus-Linthorst, M. M. A.; de Munck, L.; Pijnappel, R. M.; Schmidt, M. K.; Wesseling, J.; Koppert, L. B.; Siesling, S. Breast Cancer–Related Deaths according to Grade in Ductal Carcinoma in Situ: A Dutch Population–Based Study on Patients Diagnosed between 1999 and 2012. Eur. J. Cancer 2018, 101, 134–142. DOI: 10.1016/j.ejca.2018.07.003.
   PubMed Web of Science ®Google Scholar
• Taheripanah, R.; Balash, F.; Anbiaee, R.; Mahmoodi, M.; Akbari Sene, A. Breast Cancer and Ovulation Induction Treatments. Clin. Breast Cancer 2018, 18, 395–399. DOI: 10.1016/j.clbc.2018.03.003.
   PubMed Web of Science ®Google Scholar
• DeSantis, C.; Siegel, R.; Bandi, P.; Jemal, A. Breast Cancer Statistics, 2011. Cancer J Clin. 2011, 61, 409–418. DOI: 10.3322/caac.20134.
   PubMed Web of Science ®Google Scholar
• Daniels, B.; Kiely, B. E.; Lord, S. J.; Houssami, N.; Lu, C. Y.; Ward, R. L.; Pearson, S.-A. Trastuzumab for Metastatic Breast Cancer: Real World Outcomes from an Australian Whole-of-Population Cohort (2001–2016). The Breast 2018, 38, 7–13. DOI: 10.1016/j.breast.2017.11.007.
   PubMed Web of Science ®Google Scholar
• Patil, M.; Mehta, D. S.; Guvva, S. Future Impact of Nanotechnology on Medicine and Dentistry. J. Indian Soc. Periodontol. 2008, 12, 34–40. DOI: 10.4103/0972-124X.44088.
   PubMedGoogle Scholar
• Wong, I. Y.; Bhatia, S. N.; Toner, M. Nanotechnology: emerging Tools for Biology and Medicine. Genes Dev. 2013, 27, 2397–2408. DOI: 10.1101/gad.226837.113.
   PubMed Web of Science ®Google Scholar
• Gurunathan, S.; Kang, M.-H.; Qasim, M.; Kim, J.-H. Nanoparticle-Mediated Combination Therapy: Two-in-One Approach for Cancer. Int. J. Mol. Sci. 2018, 19, 3264. DOI: 10.3390/ijms19103264.
   PubMed Web of Science ®Google Scholar
• Senapati, S.; Mahanta, A. K.; Kumar, S.; Maiti, P. Controlled Drug Delivery Vehicles for Cancer Treatment and Their Performance. Sig. Transduct. Target. Ther. 2018, 3, 7–7. DOI: 10.1038/s41392-017-0004-3.
   PubMed Web of Science ®Google Scholar
• Gurunathan, S.; Han, J.; Park, J. H.; Kim, J.-H. A Green Chemistry Approach for Synthesizing Biocompatible Gold Nanoparticles. Nanoscale Res. Lett. 2014, 9, 248–248. DOI: 10.1186/1556-276X-9-248.
   PubMed Web of Science ®Google Scholar
• Beik, J.; Khateri, M.; Khosravi, Z.; Kamrava, S. K.; Kooranifar, S.; Ghaznavi, H.; Shakeri-Zadeh, A. Gold Nanoparticles in Combinatorial Cancer Therapy Strategies. Coord. Chem. Rev. 2019, 387, 299–324. DOI: 10.1016/j.ccr.2019.02.025.
   Web of Science ®Google Scholar
• Foroozandeh, P.; Aziz, A. A. Insight into Cellular Uptake and Intracellular Trafficking of Nanoparticles. Nanoscale Res. Lett. 2018, 13, 339–339. DOI: 10.1186/s11671-018-2728-6.
   PubMed Web of Science ®Google Scholar
• Silva, S.; Almeida, A. J.; Vale, N. Combination of Cell-Penetrating Peptides with Nanoparticles for Therapeutic Application: A Review. Biomolecules 2019, 9, 22. DOI: 10.3390/biom9010022.
   PubMed Web of Science ®Google Scholar
• Jain, S.; Coulter, J. A.; Hounsell, A. R.; Butterworth, K. T.; McMahon, S. J.; Hyland, W. B.; Muir, M. F.; Dickson, G. R.; Prise, K. M.; Currell, F. J.; et al. Cell-Specific Radiosensitization by Gold Nanoparticles at Megavoltage Radiation Energies. Int. J. Radiat. Oncol. Biol. Phys. 2011, 79, 531–539. DOI: 10.1016/j.ijrobp.2010.08.044.
   PubMed Web of Science ®Google Scholar
• Janic, B.; Brown, S. L.; Liu, F.; Mao, G.; Chetty, I. J.; Movsas, B.; Wen, N. Gold Nanoparticles as Radiosensitizers in MDA MB 231 Xenograft Mouse Model. Int. J. Radiat. Oncol. Biol. Phys. 2019, 105, E677–E678. DOI: 10.1016/j.ijrobp.2019.06.995.
   PubMed Web of Science ®Google Scholar
• Song, Y.; Ye, M.; Zhou, J.; Wang, Z.-W.; Zhu, X. Restoring E-Cadherin Expression by Natural Compounds for Anticancer Therapies in Genital and Urinary Cancers. Mol. Ther. Oncolytics 2019, 14, 130–138. DOI: 10.1016/j.omto.2019.04.005.
   PubMed Web of Science ®Google Scholar
• Corso, G.; Intra, M.; Trentin, C.; Veronesi, P.; Galimberti, V. CDH1 Germline Mutations and Hereditary Lobular Breast Cancer. Fam Cancer 2016, 15, 215–219. DOI: 10.1007/s10689-016-9869-5.
   PubMed Web of Science ®Google Scholar
• Padmanaban, V.; Krol, I.; Suhail, Y.; Szczerba, B. M.; Aceto, N.; Bader, J. S.; Ewald, A. J. E-Cadherin is Required for Metastasis in Multiple Models of Breast Cancer. Nature 2019, 573, 439–444. DOI: 10.1038/s41586-019-1526-3.
   PubMed Web of Science ®Google Scholar
• Simhadri, S.; Vincelli, G.; Huo, Y.; Misenko, S.; Foo, T. K.; Ahlskog, J.; Sørensen, C. S.; Oakley, G. G.; Ganesan, S.; Bunting, S. F.; Xia, B. PALB2 Connects BRCA1 and BRCA2 in the G2/M Checkpoint Response. Oncogene 2019, 38, 1585–1596. DOI: 10.1038/s41388-018-0535-2.
   PubMed Web of Science ®Google Scholar
• Li, J.; Li, M.; Chen, P.; Ba, Q. High Expression of PALB2 Predicts Poor Prognosis in Patients with Advanced Breast Cancer. FEBS Open Bio 2018, 8, 56–63. DOI: 10.1002/2211-5463.12356.
   PubMed Web of Science ®Google Scholar
• Lv, Z.-D.; Na, D.; Liu, F.-N.; Du, Z.-M.; Sun, Z.; Li, Z.; Ma, X.-Y.; Wang, Z.-N.; Xu, H.-M. Induction of Gastric Cancer Cell Adhesion through Transforming Growth Factor-beta1-Mediated Peritoneal Fibrosis. J. Exp. Clin. Cancer Res. 2010, 29, 139–139. DOI: 10.1186/1756-9966-29-139.
   PubMed Web of Science ®Google Scholar
• Rajabi, H.; Hiraki, M.; Tagde, A.; Alam, M.; Bouillez, A.; Christensen, C. L.; Samur, M.; Wong, K.-K.; Kufe, D. MUC1-C Activates EZH2 Expression and Function in Human Cancer Cells. Sci. Rep. 2017, 7, 7481–7413. DOI: 10.1038/s41598-017-07850-0.
   PubMed Web of Science ®Google Scholar
• Rosli, N. S.; Abdul Rahman, A.; Aziz, A. A.; Shamsuddin, S.; Zakaria, N. S. Effects of the Gold Nanoparticles (AuNPs) on the Proliferation and Morphological Characteristics of Human Breast Cancer Cells (MCF-7) in Culture. Solid State Phenom. 2017, 268, 254–258. DOI: 10.4028/www.scientific.net/SSP.268.254.
   Google Scholar
• Kamala Priya, M. R.; Iyer, P. R. Anticancer Studies of the Synthesized Gold Nanoparticles against MCF 7 Breast Cancer Cell Lines. Appl. Nanosci. 2015, 5, 443–448. DOI: 10.1007/s13204-014-0336-z.
   Web of Science ®Google Scholar
• Steckiewicz, K. P.; Barcinska, E.; Malankowska, A.; Zauszkiewicz–Pawlak, A.; Nowaczyk, G.; Zaleska-Medynska, A.; Inkielewicz-Stepniak, I. Impact of Gold Nanoparticles Shape on Their Cytotoxicity against Human Osteoblast and Osteosarcoma in in Vitro Model. Evaluation of the Safety of Use and anti-Cancer Potential. J. Mater. Sci: Mater. Med. 2019, 30, 22. DOI: 10.1007/s10856-019-6221-2.
   PubMed Web of Science ®Google Scholar
• Her, S.; Cui, L.; Bristow, R. G.; Allen, C. Dual Action Enhancement of Gold Nanoparticle Radiosensitization by Pentamidine in Triple Negative Breast Cancer. Radiat. Res. 2016, 185, 549–562. DOI: 10.1667/RR14315.1.
   PubMed Web of Science ®Google Scholar
• Alamzadeh, Z.; Beik, J.; Pirhajati Mahabadi, V.; Abbasian Ardekani, A.; Ghader, A.; Kamrava, S. K.; Shiralizadeh Dezfuli, A.; Ghaznavi, H.; Shakeri-Zadeh, A. Ultrastructural and Optical Characteristics of Cancer Cells Treated by a Nanotechnology Based Chemo-Photothermal Therapy Method. J. Photochem. Photobiol. B 2019, 192, 19–25. DOI: 10.1016/j.jphotobiol.2019.01.005.
   PubMed Web of Science ®Google Scholar
• Mirrahimi, M.; Khateri, M.; Beik, J.; Ghoreishi, F. S.; Dezfuli, A. S.; Ghaznavi, H.; Shakeri-Zadeh, A. Enhancement of Chemoradiation by co-Incorporation of Gold Nanoparticles and Cisplatin into Alginate Hydrogel. J. Biomed. Mater. Res. 2019, 107, 2658–2663. DOI: 10.1002/jbm.b.34356.
   Web of Science ®Google Scholar
• Evan, G. I.; Vousden, K. H. Proliferation, Cell Cycle and Apoptosis in Cancer. Nature 2001, 411, 342–348. DOI: 10.1038/35077213.
   PubMed Web of Science ®Google Scholar
• Choi, S. Y.; Jeong, S.; Jang, S. H.; Park, J.; Park, J. H.; Ock, K. S.; Lee, S. Y.; Joo, S. W. In Vitro Toxicity of Serum Protein-Adsorbed Citrate-Reduced Gold Nanoparticles in Human Lung Adenocarcinoma Cells. Toxicol. in Vitro 2012, 26, 229–237. DOI: 10.1016/j.tiv.2011.11.016.
   PubMed Web of Science ®Google Scholar
• Lee, D. G.; Go, E. B.; Lee, M.; Pak, P. J.; Kim, J.-S.; Chung, N. Gold Nanoparticles Conjugated with Resveratrol Induce Cell Cycle Arrest in MCF-7 Cell Lines. Appl. Biol. Chem. 2019, 62, 33. DOI: 10.1186/s13765-019-0440-6.
   Web of Science ®Google Scholar
• Lara-Cruz, C.; Jimenez-Salazar, J. E.; Arteaga, M.; Arredondo, M.; Ramon-Gallegos, E.; Batina, N.; Damian-Matsumura, P. Gold Nanoparticle Uptake is Enhanced by Estradiol in MCF-7 Breast Cancer Cells. Int. J. Nanomed. 2019, 14, 2705–2718. DOI: 10.2147/IJN.S196683.
   PubMed Web of Science ®Google Scholar
• Balakrishnan, S.; Bhat, F. A.; Raja Singh, P.; Mukherjee, S.; Elumalai, P.; Das, S.; Patra, C. R.; Arunakaran, J. Gold Nanoparticle-Conjugated Quercetin Inhibits Epithelial-Mesenchymal Transition, Angiogenesis and Invasiveness via EGFR/VEGFR-2-Mediated Pathway in Breast Cancer. Cell Prolif. 2016, 49, 678–697. DOI: 10.1111/cpr.12296.
   PubMed Web of Science ®Google Scholar
• Han, X.; Jiang, X.; Guo, L.; Wang, Y.; Veeraraghavan, V. P.; Krishna Mohan, S.; Wang, Z.; Cao, D. Anticarcinogenic Potential of Gold Nanoparticles Synthesized from Trichosanthes Kirilowii in Colon Cancer Cells through the Induction of Apoptotic Pathway. Artif. Cells. Nanomed. Biotechnol. 2019, 47, 3577–3584. DOI: 10.1080/21691401.2019.1626412.
   PubMed Web of Science ®Google Scholar
• Loutfy, S. A.; Al-Ansary, N. A.; Abdel-Ghani, N. T.; Hamed, A. R.; Mohamed, M. B.; Craik, J. D.; Salah Eldin, T. A.; Abdellah, A. M.; Hussein, Y.; Hasanin, M. T. M.; Elbehairi, S. E. I. Anti-Proliferative Activities of Metallic Nanoparticles in an in Vitro Breast Cancer Model. Asian Pac. J. Cancer Prev. 2015, 16, 6039–6046. DOI: 10.7314/APJCP.2015.16.14.6039.
   PubMedGoogle Scholar
• Xia, B.; Sheng, Q.; Nakanishi, K.; Ohashi, A.; Wu, J.; Christ, N.; Liu, X.; Jasin, M.; Couch, F. J.; Livingston, D. M. Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2. Mol. Cell 2006, 22, 719–729. DOI: 10.1016/j.molcel.2006.05.022.
   PubMed Web of Science ®Google Scholar
• Antoniou, A. C.; Casadei, S.; Heikkinen, T.; Barrowdale, D.; Pylkäs, K.; Roberts, J.; Lee, A.; Subramanian, D.; De Leeneer, K.; Fostira, F.; et al. Breast-Cancer Risk in Families with Mutations in PALB2. N Engl. J. Med. 2014, 371, 497–506. DOI: 10.1056/NEJMoa1400382.
   PubMed Web of Science ®Google Scholar